UPDATE 1-Auris's tinnitus drug misses main goals in study; shares sink

Aug 18 (Reuters) - Auris Medical Holding AG said

its experimental drug for acute inner ear tinnitus missed the

main goals of a late-stage study, sending its shares down more

than 40 percent in...

Read more